| NCT05194735 | Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2022-04-04 | 2024-11-30 | 2024-11-30 |
| NCT04006119 | Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma | TERMINATED | PHASE2 | 2019-08-01 | 2021-08-05 | 2021-08-05 |
| NCT03679754 | Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102 | COMPLETED | PHASE1 | 2018-09-05 | 2021-01-19 | 2019-04-02 |
| NCT03636477 | A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102 | COMPLETED | PHASE1 | 2018-06-18 | 2021-06-30 | 2020-10-15 |
| NCT03330197 | A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG | TERMINATED | PHASE1, PHASE2 | 2017-09-26 | 2021-09-10 | 2021-09-10 |
| NCT02423902 | A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer | TERMINATED | PHASE1, PHASE2 | 2015-07-18 | 2016-07-19 | 2016-07-19 |
| NCT02026271 | A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma | COMPLETED | PHASE1 | 2015-06 | 2019-08 | 2019-08 |
| NCT01703754 | Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer. | TERMINATED | PHASE2 | 2013-04-04 | 2014-08-07 | 2014-08-07 |
| NCT01555710 | Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) | UNKNOWN | PHASE3 | 2012-05 | 2015-06 | 2015-06 |
| NCT01397708 | Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma | COMPLETED | PHASE1, PHASE2 | 2011-08 | 2014-09 | 2014-09 |
| NCT01340547 | Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors | UNKNOWN | PHASE1 | 2011-06 | 2013-09 | 2013-09 |
| NCT01242072 | Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies | UNKNOWN | PHASE1 | 2010-11 | 2012-12 | 2012-12 |
| NCT01168791 | Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma | COMPLETED | PHASE3 | 2010-07 | 2013-03 | 2013-03 |
| NCT01139346 | Study of Oral Darinaparsin in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2010-06 | 2012-04 | 2012-04 |
| NCT01139359 | Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma | WITHDRAWN | PHASE1 | 2010-06 | 2011-06 | 2011-06 |
| NCT01113970 | Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer | UNKNOWN | PHASE1, PHASE2 | 2010-03 | 2013-05 | 2013-05 |
| NCT00815607 | Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma | COMPLETED | PHASE1 | 2009-04 | 2013-01 | 2013-01 |
| NCT00718484 | A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma | UNKNOWN | PHASE2 | 2008-08 | 2014-04 | 2012-04 |
| NCT00726687 | Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors | UNKNOWN | PHASE1, PHASE2 | 2008-06 | 2013-06 | 2013-06 |
| NCT00607711 | Study of Oral Palifosfamide Tris in Solid Tumors | SUSPENDED | PHASE1 | 2008-03 | 2009-11 | 2009-11 |
| NCT00591383 | Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors | UNKNOWN | PHASE1 | 2008-01 | 2013-06 | 2013-06 |
| NCT00608803 | Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors | COMPLETED | PHASE1 | 2008-01 | 2009-01 | 2009-01 |
| NCT00592163 | Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas | UNKNOWN | PHASE1 | 2007-12 | 2013-06 | 2013-06 |
| NCT00591890 | Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans | COMPLETED | PHASE1 | 2007-10 | 2009-03 | 2008-06 |
| NCT00591422 | Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas | UNKNOWN | PHASE1 | 2007-08 | 2013-06 | 2013-06 |
| NCT00591292 | Phase I Study in Advanced Solid Tumors | UNKNOWN | PHASE1 | 2007-06 | 2013-06 | 2013-06 |
| NCT00423644 | A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b | UNKNOWN | PHASE2 | 2007-01 | 2013-12 | 2013-12 |
| NCT00423306 | A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma | UNKNOWN | PHASE2 | 2007-01 | 2013-12 | 2013-12 |
| NCT00421213 | Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers | COMPLETED | PHASE2 | 2006-12 | 2012-04 | 2012-04 |
| NCT00439686 | Study of ZIO-201 in Advanced Sarcoma | COMPLETED | PHASE1, PHASE2 | 2006-02 | 2013-12 | 2008-06 |
| NCT00421135 | A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer | COMPLETED | PHASE1 | 2006-02 | 2007-10 | 2007-10 |
| NCT00303199 | Study of ZIO-101 in Multiple Myeloma | COMPLETED | PHASE1, PHASE2 | 2006-01 | 2007-08 | 2007-08 |
| NCT00591396 | A Phase I Trial of ZIO-101 in Solid Tumors | COMPLETED | PHASE1 | 2005-07 | 2008-07 | 2008-07 |
| NCT00592046 | A Phase I Trial of ZIO-101 in Hematologic Cancers | COMPLETED | PHASE1 | 2005-05 | 2008-06 | 2008-06 |
| NCT00591136 | Phase I Study of Indibulin in Patients With Solid Tumors | COMPLETED | PHASE1 | 2003-04 | 2008-09 | 2008-09 |